Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

95 results about "Aminothiazole" patented technology

2-Aminothiazole is a heterocyclic amine featuring a thiazole core. It can also be considered a cyclic isothiourea. It possesses an odor similar to pyridine and is soluble in water, alcohols and diethyl ether. It is commonly used as a starting point for the synthesis of many compounds including sulfur drugs, biocides, fungicides, dyes and chemical reaction accelerators. 2-Aminothiazole can be used as a thyroid inhibitor in the treatment of hyperthyroidism and has antibacterial activity. Alternatively, its acid tartrate salt can be used. Recent studies using prion-infected neuroblastoma cell lines have suggested that aminothiazole may be used as a therapeutic drug for prion diseases.

Preparation and application of substituted benzimino thiazolidone derivative

The invention relates to a preparation method and an application of a substituted benzimino thiazolidone derivative. Specifically, the invention relates to a compound as shown in a formula (I), or an isotope labeled compound thereof, or an optical isomer, a geometric isomer, a tautomer or an isomer mixture thereof, or a pharmaceutically acceptable salt thereof, and application of the compound in preparation of insecticides for pest control. The compound can achieve a better pest control effect at a lower dosage, especially for pests such as tetranychidae, microcosaridae, acaridae, tarsonidae, aleuridae and root-knot nematode, and can be used for controlling pests such as tetranychidae, microcosaridae, gall mite, tarsonidae, aleuridae and the like. # imgabs0 #
Owner:ZHEJIANG HISUN CHEM CO LTD

Electrochemical synthesis of 2-aminothiazole compounds

The present invention relates to an electrochemical synthesis method of 2-aminothiazole compounds with the structural formula shown below: 1 =4‑Me‑, 3‑Me‑, 2‑Me‑, 4‑Et‑, 4‑MeO‑, 4‑OH‑, 4‑F‑, 4‑Cl‑, 3‑Cl‑, 2‑Cl‑.R 2 =H, Me, Et, Ph. The main process is: in a single-chamber electrolytic cell, ketone (0.589 g, 3 mmol), thiourea (0.076 g, 1 mmol), anhydrous ammonium iodide (0.145 g, 1 mmol), TsOH·H 2 O (0.951g, 5mmol), DMSO (10ml), H 2 O (5ml). Both the cathode and the anode are inserted into graphite sheets, and the current density is 5mA / cm 2 The reaction temperature was 70°C and the current was 3F / mol. The corresponding 2-aminothiazole compound 3 was obtained with a yield of 38-72%.
Owner:BEIJING TECH & BUSINESS UNIV

Lead-free phosphorus chemical nickel plating solution

The invention discloses a lead-free phosphorus chemical nickel plating solution, and relates to the field of chemical nickel plating, and the lead-free phosphorus chemical nickel plating solution comprises the following components: 6-10 g / L of nickel salt, 5-10 g / L of a complexing agent, 1-5 g / L of a brightener, 5-12 g / L of a reducing agent, 0.6-0.9 g / L of a composite stabilizer, 2-10 g / L of a plating starting agent, 0.1-0.6 g / L of a hydrogen evolution preventing agent and 30-60 mg / L of a surfactant. The adopted plating starting agent is high in decomposition capacity, after the service cycle is increased to 4 MTO, the problem that decomposition products are accumulatively increased to a certain degree to cause blackening of a plating layer can be relieved, 5-6 MTO can be achieved, meanwhile, the adopted composite stabilizer is a composition composed of an aminopyrrole carboxylic ester compound and an aminothiazole carboxylic ester compound, and the composite stabilizer has the beneficial effects of being environmentally friendly and free of pollution. The stability of traditional elements such as lead and cadmium can be improved, and the problem that the service cycle of stabilizers such as benzotriazole or sodium thiosulfate is short can be solved.
Owner:ZHUHAI LIANDING CHEM EQUIP CO LTD

Sulfonamidothiazolyl resorcinol derivative and application thereof in preparation of tyrosinase inhibitor and whitening cosmetics

The invention discloses a sulfanilamide thiazolyl resorcinol derivative and application of the sulfanilamide thiazolyl resorcinol derivative in preparation of a tyrosinase inhibitor and whitening cosmetics. The structural formula of the derivative is # imgabs0 #, in the formula, R represents a fat (aromatic) group substituent, and R'represents a hydrogen atom or methyl; the preparation method comprises the following steps: taking 2-chloro-1-(2, 4-dimethoxyphenyl) ethanone as an initial raw material, carrying out cyclization condensation on the 2-chloro-1-(2, 4-dimethoxyphenyl) ethanone and thiourea to obtain 4-(2-amino-1, 3-thiazole-4-yl) benzene-1, 3-dimethanol, carrying out reaction on 2-amino of thiazole and different fat (aromatic) sulfonyl chloride, and then removing methyl to prepare the 4-(2-amino-1, 3-thiazole-4-yl) benzene-1, 3-dimethanol. Pharmacological activity tests show that the compound has good inhibitory activity on tyrosinase, which indicates that the sulfanilamide thiazolyl resorcinol derivative can be researched and utilized as a novel tyrosinase inhibitor and whitening cosmetics.
Owner:NORTHWEST UNIV

2-aminothiazolyl rhodamine 6G derivative as well as preparation method and application thereof

The invention belongs to an advanced material technology, and relates to a novel rhodamine derivative, in particular to a 2-aminothiazolyl rhodamine 6G derivative as well as a preparation method and application thereof. Rhodamine 6G and 2-aminothiazole are used as raw materials, the 2-aminothiazolyl rhodamine 6G derivative RGAT is prepared through a one-step reaction, on one hand, RGAT shows excellent selectivity and very high sensitivity to Fe < 3 + >, fluorescence enhancement is remarkable, the linear range of Fe < 3 + > is wide, in the Fe < 3 + > concentration range of 0-50 M, a good linear relation with the Fe < 3 + > concentration is shown, and the detection limit is as low as 2.4 nM; on the other hand, the RGAT has better antibacterial performance on gram-positive bacteria and gram-negative bacteria than commercially available bleaching water, and the RGAT is very low in cytotoxicity, so that the RGAT has a good application prospect in the fields of environmental monitoring and biological medicine.
Owner:SUZHOU UNIV

Application of aminothiazole derivative in preparation of medicine for treating alcoholic liver disease

The invention relates to the field of biological medicine, in particular to application of an aminothiazole derivative in medicine for preventing, relieving or treating alcoholic liver diseases, and the aminothiazole derivative achieves the effect of inhibiting inflammation signal transduction by targeted inhibition of activation of MyD88 molecules in a TLRs-Myd88-NF-kappa B pro-inflammatory signal channel in the alcoholic liver diseases. The inflammatory process of the alcoholic liver disease caused by excessive drinking can be relieved, and the liver inflammatory microenvironment induced by alcohol is improved, so that the effect of treating the alcoholic liver disease is achieved. According to the invention, INNA1605 is used for inhibiting alcohol-induced liver inflammation for the first time so as to improve the alcoholic liver disease, a foundation is laid for further drug research and development, and the application has a potential treatment application prospect.
Owner:WUHAN YINGNUO PHARMACEUTICAL CO LTD

Preparation method for chiral synthesis of high-purity levamisole hydrochloride

The invention discloses a preparation method for chiral synthesis of high-purity levamisole hydrochloride. (R)-styrene oxide is used as an initial raw material, and the (R)-styrene oxide and 2-aminothiazoline are subjected to condensation, cyclization and salification to obtain the levamisole hydrochloride. According to the invention, a chiral synthesis process is adopted, so that the working procedures of resolution and dextroisomer racemization are avoided, and the synthesis route is shortened; reaction conditions are mild, and racemization in the synthesis process is reduced; the method is simple and convenient to operate and suitable for industrial production, the optical purity can reach 99.0% or above, and the single impurity content is smaller than 0.1%. The invention also provides a key technology for controlling initial raw materials, intermediates and finished product optical isomers in the whole chiral synthesis process.
Owner:CHANGZHOU YABANG QH PHARMACHEM +2

Method and system for detecting ritonavir intermediate

The invention belongs to the technical field of ritonavir intermediate detection, and particularly provides a ritonavir intermediate detection method and a ritonavir intermediate detection system, acetonitrile-water (20: 80) is used as a diluent for dissolution, quantitative dilution is carried out to prepare a solution, each 1ml of the diluent contains 1.0 mg of (2S, 3S, 5S)-5-amino-2-(N-((5-thiazolyl)-methoxycarbonyl) amino)-1, 6-diphenyl-3-hydroxyhexane hydrochloride, and the solution is used for detecting the ritonavir intermediate. 5 microliters of the sample solution is taken and injected into a liquid chromatograph, a chromatogram is recorded, and the purity and the impurity content of the chromatogram are detected; according to the method, a high performance liquid chromatography is adopted, acetonitrile-water (20: 80) is used as a diluent to measure the ritonavir intermediate, the separation degree of all related substances of (2S, 3S, 5S)-5-amino-2-(N-((5-thiazolyl)-methoxycarbonyl) amino)-1, 6-diphenyl-3-hydroxyhexane hydrochloride in the method meets the requirement, a test sample is convenient to prepare, and the method is suitable for large-scale industrial production. And the stability of the test solution is better.
Owner:WUHAN HAITE BIOLOGICAL INNOVATIVE PHARM RES CO LTD

Application of aminothiazole derivative in preparation of medicine for treating diseases caused by high fat diet

The invention discloses application of an aminothiazole derivative in preparation of a medicine for preventing, relieving or treating diseases caused by high fat diet, and relates to the technical field of biological medicine. The aminothiazole derivative resists obesity and recovers the steady state of intestinal flora by inhibiting the obesity inflammation process and regulating food intake, can be used as a diet regulator, an intestinal flora restorer and an inflammation inhibitor for high-fat diet related diseases such as obesity, non-alcoholic fatty liver, type II diabetes and the like, and has the advantages of good safety and good effect. It is found for the first time that the MyD88 inhibitor INNA1605 can relieve obesity by controlling intake of high-fat diet, meanwhile, the MyD88 inhibitor INNA1605 has a certain recovery effect on intestinal flora homeostasis, and the MyD88 inhibitor INNA1605 not only serves as a targeted inflammation inhibitor to relieve obesity, but also can serve as an intestinal homeostasis regulator and a diet regulator to treat obesity.
Owner:WUHAN YINGNUO PHARMACEUTICAL CO LTD

2-aminothiazole compound derivative and use thereof

Provided in the present invention are a 2-aminothiazole compound derivative and the use thereof. The compound has a chemical structure of general formula (I) as shown in the following formula. The compound derivative provided in the present invention has an inhibitory activity against dihydroorotate dehydrogenase (DHODH), and is expected to be used in the preparation of a drug for preventing and / or treating diseases related to DHODH.
Owner:FUDAN UNIVERSITY

Substituted aminothiazoles as DGKZETA inhibitors for immune activation

The present invention relates to aminothiazole compounds of general formula (I), wherein R 1 , R 2 , R 3 and R 4 as defined herein, and also relates to methods for preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds as a single agent or in combination with other active ingredients in the preparation of pharmaceutical compositions for the treatment and / or prevention of diseases, in particular diseases regulated by diacylglycerol kinase ζ (DGKζ).
Owner:BAYER AG

Application of aminothiazole compound in preparation of medicine for treating xerophthalmia and medicine composition

The invention relates to the technical field of biological medicine, in particular to application of an aminothiazole compound in preparation of a medicine for treating xerophthalmia and a medicine composition, and specifically, the aminothiazole compound INNA1605 is used for treating the xerophthalmia. Mouse experiments find that the aminothiazole compound INNA1605 with the concentration being 0.5% or above has a good treatment effect on the xerophthalmia, the compound can increase the secretion amount of tears of a patient suffering from the xerophthalmia, the treatment effect is in positive correlation with the dosage, no obvious adverse reaction exists, and no irritation is caused to eyes. The aminothiazole compound INNA1605 is helpful for alleviating ocular surface injury caused by xerophthalmia, and is helpful for protecting corneal epithelium and conjunctival goblet cells of eyes. Through the effects, INNA1605 is expected to provide an effective medicine for relieving and treating xerophthalmia.
Owner:WUHAN YINGNUO PHARMACEUTICAL CO LTD

Preparation method and application of Mannich base thiadiazole quaternary ammonium salt corrosion inhibitor for methanesulfonic acid pickling

The invention relates to the technical field of corrosion inhibitors in the pickling industry, in particular to a preparation method and application of a Mannich base thiadiazole quaternary ammonium salt corrosion inhibitor for methanesulfonic acid pickling. According to the method, amino thiadiazole is modified by Mannich, quaternization is further performed, and the thiadiazole corrosion inhibitor with the advantages of Mannich base and quaternary ammonium salt is obtained. Quaternary ammonium salt groups in corrosion inhibitor molecules endow the corrosion inhibitor with good water solubility, and the dispersity and adsorbability of the corrosion inhibitor in an acid solution are improved; thiadiazole ring, thioamide and the like contained in the corrosion inhibitor contain N and S atom groups, so that coordination with metal is facilitated, and the adsorption performance of the corrosion inhibitor is improved; and the tail alkyl chain can effectively isolate corrosive substances from being in contact with a metal matrix. The preparation method is simple in synthesis step and low in raw material cost, and the obtained corrosion inhibitor is excellent in corrosion inhibition effect. Under the condition of 353 K, the highest corrosion inhibitor efficiency on Q235 steel in methanesulfonic acid with the molar concentration of 0.5 M reaches 99.8%.
Owner:KUNSHI CONTAINER MFG CO LTD +1

Substituted aminothiazoles as DGKzeta inhibitors for immune activation

ActiveUS12673927B2ThiazoleGlycerol kinase
The present invention covers aminothiazole compounds of general formula (I), in which R1, R2, R3 and R4 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and / or prophylaxis of diseases, in particular of diacylglycerol kinase zeta (DGKζ) regulated disorders, as a sole agent or in combination with other active ingredients.
Owner:DEUTES KREBSFORSCHUNGSZENT STIFTUNG DES OFFENTLICHEN RECHTS

Tumor inhibition preparation based on Ackermania muciniphila

The invention discloses a tumor inhibition preparation based on Ackermania muciniphila, and belongs to the field of tumor medicine.AKK and tumor cells are mixed according to a certain proportion and jointly injected into a mouse body, and it is found that AKK can inhibit growth of the tumor cells and can survive for at least 7 days in the tumor cells; in addition, the effect of AKK in a living body is better than that of AKK in a dead body, the AKK is mixed in a bioactive solution to prepare the tumor inhibition preparation based on Ackermania muciniphila, and an auxiliary agent glucosamino acid conjugate can be added in the preparation of the tumor inhibition preparation, so that the AKK-based tumor inhibition preparation can be used for preparing the tumor inhibition preparation based on Ackermania muciniphila and the AKK-based tumor inhibition preparation based on Ackermania muciniphila. The glucosamine acid conjugate has a glucosamine group and a 2-aminothiazole-5-carboxylic acid ester group, which are coupled by a succinic acid. The ackermansiella muciniphila-based tumor inhibition preparation provided by the invention has a good inhibition effect on tumor cells, is good in safety and can be used for preparing anti-tumor drugs.
Owner:ZHEJIANG PROVINCIAL PEOPLES HOSPITAL

Solid preparation of sustained-release pharmaceutical composition

To provide a solid preparation of a sustained-release pharmaceutical composition in which even a solid preparation has excellent structural stability while maintaining an effect of sustained-release of a pharmaceutical composition.SOLUTION: A solid preparation of a sustained-release pharmaceutical composition contains: (1) (R)-2-(2-aminothiazole-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl] acetic acid anilide or a pharmaceutically acceptable salt thereof; (2) one or more kinds of polymeric substances which form hydrogel having the average molecular weight of 100,000 or more or in which 5% aqueous solution has viscosity of 25°C 12 mPa s or more; and (3) one or more kinds of non-hydrophilic additives showing dissolubility that [amount of water for dissolving 1 g at 20±5°C exceeds 10 mL], where the solid preparation without considering coating does not contain a hydrophilic component showing dissolubility that [amount of water for dissolving 1 g at 20±5°C is 10 mL or less] other than a polymeric substance forming hydrogel of the component (2).SELECTED DRAWING: Figure 2
Owner:STANDARD CHEM & PHARMA CO LTD

Photosensitive surfactant and application thereof in Knoevenagel reaction

The invention discloses a photosensitive surfactant, a preparation method of the photosensitive surfactant, and an application of the photosensitive surfactant in a Knoevenagel condensation reaction. The preparation method comprises the following steps: reacting 2-aminothiazole with 2-fluorophenol to obtain thiazole azophenol, then reacting the thiazole azophenol with dibromoalkane with different chain lengths to generate an intermediate, carrying out an addition reaction on the obtained intermediate and trimethylamine, and purifying to obtain the photosensitive surfactant. Compared with a traditional photosensitive surfactant, the photosensitive surfactant prepared by the invention can realize reversible conversion between cis-isomer and trans-isomer under irradiation of visible light with different wavelengths, and is applied to a Knoevenagel condensation reaction; the problems that in the Knoevenagel condensation reaction, a catalyst needs to be added, a large amount of organic solvent is used, and product separation is tedious can be solved.
Owner:FUZHOU UNIV

Preparation method and application of high-coordination lignin conductive hydrogel

PendingCN119842100ALithium chlorideThiazole
The invention discloses a preparation method and application of high-coordination lignin conductive hydrogel, and belongs to the technical field of conductive hydrogel, the preparation method comprises the following steps: reacting an aminothiazole compound with chloroalkyl acyl chloride under an alkaline condition to prepare a chloroalkyl amide bidentate coordination precursor; the preparation method comprises the following steps: reacting lignin with lactone to obtain a hydroxyalkyl lignin derivative; the preparation method comprises the following steps: carrying out substitution reaction on a hydroxyalkyl lignin derivative and a chloro alkyl amide bidentate coordination precursor under an alkaline condition to prepare bidentate coordination modified lignin; and adding the bidentate coordination modified lignin into a polyvinyl alcohol solution, uniformly mixing, stirring in a dark place, pouring into a mold, and soaking the mold and the hydrogel in an ionic solution of lithium chloride to prepare the high-coordination lignin conductive hydrogel. A chloroalkyl amide bidentate coordination precursor synthesized by reacting an aminothiazole compound with alkyl acyl chloride is coordinated with hydroxyalkyl lignin to obtain modified lignin with a strong coordination effect, and the modified lignin is coordinated with lithium ions to form a stable complex, so that the high-conductivity ionic conductive hydrogel is obtained.
Owner:JIANGSU UNIV OF TECH

Method for detecting 2-aminothiazole in marine sediments in sea area near offshore wind field

The invention relates to the technical field of detection, and particularly discloses a method for detecting 2-aminothiazole in marine sediments in a sea area near an offshore wind field, which comprises the following steps: extracting a sample by using a mixed solution, then deriving by using hexyl chloroformate, converting a target compound 2-aminothiazole into N-(thiazole-2-yl) carbamic acid n-hexyl ester, and detecting the 2-aminothiazole in the marine sediments in the sea area near the offshore wind field by using the N-(thiazole-2-yl) carbamic acid n-hexyl ester. And enriching and purifying the obtained derivative by using a solid-phase extraction small column, and detecting by using a liquid chromatography-mass spectrometry system. The method provided by the invention can be used for efficiently, quickly and accurately analyzing and detecting, and is suitable for detecting 2-aminothiazole in marine sediments.
Owner:THREE GORGES NEW ENERGY (YANTAI MUPING DISTRICT) CO LTD +4

Aminothiazole compounds as protein kinase inhibitors

The present invention discloses aminothiazole compounds of the following formula (I) and pharmaceutical compositions containing one of these compounds. The present invention also discloses methods for inhibiting tyrosine kinase and treating cancers associated with tyrosine kinase using one of the aminothiazole compounds.
Owner:NATIONAL HEALTH RESEARCH INSTITUTE

Isobutyrylaminothiazolyl resorcinyl dipalmitate, its preparation process and application

PendingCN122355974AThiazoleWhitening Agents
The application discloses isobutyryl amino thiazyl resorcinol dipalmitate and a preparation method and application thereof. The compound is successfully prepared by performing an acylation reaction on isobutyryl amino thiazyl resorcinol and palmitic acid. Experiments prove that, compared with the prior art, the compound not only retains excellent whitening efficacy, but also exhibits extremely low cytotoxicity and significant soothing efficacy. The compound has whitening, soothing and high safety, overcomes the defect that traditional whitening agents are strong in irritation, and can be directly applied to cosmetics or skin external drugs, and has extremely high industrial value.
Owner:GUANGDONG DINGCHUN BIOMEDICAL TECHNOLOGY CO LTD

Substituted aminothiazoles as dgkzeta inhibitors for immune activation

To provide compounds for the treatment and / or prophylaxis of diacylglycerol kinase zeta (DGKζ) regulated disorders.SOLUTION: The present invention relates to an aminothiazole compound represented by the following formula (I).SELECTED DRAWING: None
Owner:BAYER AG

Preparation method of concentration-dependent red light sulfur quantum dots and sulfur quantum dots

The application discloses a preparation method of concentration-dependent red light sulfur quantum dots and the red light sulfur quantum dots. The preparation method comprises the following steps: grinding, and reacting with sublimed sulfur, inorganic alkali and a heterocyclic functional reagent as raw materials and hydrogen peroxide as an etching agent; and then performing dialysis and freeze-drying to obtain the red light sulfur quantum dots. The heterocyclic functional reagent is a nitrogen-containing heterocyclic compound, and is at least one of 2-aminothiazole, imidazole-2-formaldehyde and 2-aminooxazole. The three SQDs all have concentration dependence, and the optimal emission wavelength is gradually red-shifted with the increase of the SQD concentration, and the maximum red shift is 130 nm. The maximum emission wavelength of the prepared SQDs can reach 690 nm, which indicates that the SQDs are red light emission fluorescent nanomaterials, and the fluorescence wavelength red shift can be attributed to non-radiative transition due to molecular assembly at a high concentration, i.e. fluorescence resonance energy transfer, and production of new emission centers. The application provides a new strategy for the research of concentration-dependent nanomaterials and red light emission SQDs.
Owner:GANNAN MEDICAL UNIV

A flash etching fluid, its preparation method and application

This invention relates to a flash etching solution, its preparation method, and its application. The flash etching solution comprises hydrogen peroxide, sulfuric acid, a corrosion inhibitor, a stabilizer, and water; the corrosion inhibitor comprises a combination of aminotetrazole, hydroxyethyl ethylenediaminetriacetic acid, and 2-aminothiazole. The flash etching solution provided by this invention significantly improves the stability of hydrogen peroxide, greatly extending its service life; and effectively improves problems such as large lateral corrosion and high roughness, thereby improving production efficiency and reducing production costs.
Owner:JIANGSU AISEN SEMICON MATERIAL CO LTD +1

A 2-aminothiazolyl rhodamine 6G derivative, its preparation method and application

The present invention belongs to the field of advanced materials technology, and relates to a new rhodamine derivative, specifically to a 2-aminothiazolyl rhodamine 6G derivative and its preparation method and application. The present invention uses rhodamine 6G and 2-aminothiazole as raw materials to prepare the 2-aminothiazolyl rhodamine 6G derivative RGAT in a one-step reaction. On the one hand, RGAT shows excellent selectivity and high sensitivity to Fe<supgt;3+< / supgt>, with a significant fluorescence enhancement, a wide linear range for Fe<supgt;3+< / supgt>, and a good linear relationship with the Fe<supgt;3+< / supgt> concentration in the range of 0-50 µM of Fe<supgt;3+< / supgt> concentration, and the detection limit is as low as 2.4 nM. On the other hand, RGAT has antibacterial properties superior to commercially available bleach against both Gram-positive and Gram-negative bacteria, and RGAT has very low cytotoxicity, showing good application prospects in the fields of environmental monitoring and biomedicine.
Owner:SUZHOU UNIV

High-strength modified polypropylene composite material and preparation process thereof

PendingCN122011581AMethacrylatePolymer science
The invention discloses a high-strength modified polypropylene composite material and a preparation process thereof, and relates to the technical field of polypropylene composite materials. The high-strength modified polypropylene composite material comprises the following raw materials in parts by weight: 60-70 parts of polypropylene, 15-18 parts of modified glass fibers and 5-6 parts of a thiazolyl phosphorus-containing flame retardant. The preparation method comprises the following steps: sequentially reacting phosphorus oxychloride with p-hydroxybenzaldehyde and 2-aminothiazole to obtain a thiazolyl phosphorus-containing flame retardant; the preparation method comprises the following steps: sequentially reacting glass fibers with 3-chloropropyltriethoxysilane and tetraethylenepentamine to prepare aminated glass fibers; and carrying out a reaction on the aminated glass fiber, acrylate-based hindered phenol and 2-[3-(2H-benzotriazole-2-yl)-4-hydroxyphenyl] ethyl 2-methacrylate to prepare the modified glass fiber. The modified glass fiber and the thiazolyl phosphorus-containing flame retardant are added into polypropylene, so that the polypropylene composite material is endowed with excellent flame retardance, weather resistance and mechanical properties.
Owner:SHENZHEN XINGBAOCHANG IND CO LTD

Preparation method of ceftriaxone sodium

PendingCN120574923AFermentationCeftriaxonumMethylating Agent
The invention relates to a preparation method of ceftriaxone sodium, which comprises the following steps: (1) mixing aminothiazole acetic acid, an organic solvent and ethylene glycol, dropwise adding thionyl chloride to carry out primary reaction, concentrating the reaction liquid after the reaction is finished, then adding the organic solvent again and dropwise adding thionyl chloride to carry out secondary reaction to obtain chloroethanol aminothiazole acetate; (2) reacting the chloroethanol aminothiazole acetate with 7-ACT in the presence of immobilized penicillin acylase for synthesis to generate a first intermediate product; (3) reacting the first intermediate product with tert-butyl nitrite under an acidic condition to generate a second intermediate product; (4) reacting the second intermediate product with a methylation reagent under the action of a base catalyst to generate ceftriaxone acid; and (5) reacting the ceftriaxone acid with an inorganic base to generate the ceftriaxone sodium. The preparation method disclosed by the invention is mild in reaction, green and environment-friendly, high in yield and high in purity.
Owner:SUZHOU DAWNRAYS PHARM CO LTD